Scholarly Index
Alan D. D’Andrea
Dana-Farber Cancer Institute; 51,088 total citations; 465 total publications; best world rank #6
Dana-Farber Cancer Institute
51,088Total citations
465Total publications
120H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| DNA Repair Mechanisms | Lifetime | 9 | US 6 | 99.87 |
| PARP inhibition in cancer therapy | Lifetime | 6 | US 2 | 99.72 |
| CRISPR and Genetic Engineering | Lifetime | 42 | US 33 | 99.75 |
| Carcinogens and Genotoxicity Assessment | Lifetime | 48 | US 27 | 99.54 |
| Ubiquitin and proteasome pathways | Lifetime | 172 | US 93 | 99.10 |
| BRCA gene mutations in cancer | Lifetime | 95 | US 50 | 99.12 |
| Erythropoietin and Anemia Treatment | Lifetime | 45 | US 19 | 99.06 |
| Cancer-related Molecular Pathways | Lifetime | 291 | US 170 | 98.94 |
| Microtubule and mitosis dynamics | Lifetime | 232 | US 143 | 98.11 |
| Erythrocyte Function and Pathophysiology | Lifetime | 301 | US 173 | 97.98 |
| Genomics and Chromatin Dynamics | Lifetime | 566 | US 326 | 97.62 |
| DNA Repair Mechanisms | 2021-2025 | 15 | US 9 | 98.16 |
| PARP inhibition in cancer therapy | 2021-2025 | 95 | US 40 | 96.29 |
| Cancer-related Molecular Pathways | 2021-2025 | 202 | US 88 | 89.96 |